National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

TEMPI syndrome


Other Names:
Telangiectasia - Erythrocytosis - Monoclonal gammopathy - Perinephric-fluid collections - Intrapulmonary shunting
TEMPI syndrome is a newly discovered, multisystem condition named for 5 characteristics that affected individuals have: Telangiectasias, Erythrocytosis with elevated erythropoietin level, Monoclonal gammopathy, Perinephric-fluid collections (fluid around the kidney), and Intrapulmonary shunting (when a region of the lungs is supplied with blood but with little or no ventilation).[1] Signs and symptoms of TEMPI syndrome have appeared in mid-adulthood in all known affected individuals. The telangiectasias develop mostly on the face, trunk and arms. The intrapulmonary shunt causes hypoxia (not enough oxygen supply), which slowly progresses until the person needs continuous supplemental oxygen to support their breathing. Blood clots and bleeding in the brain have also been reported in some affected individuals. The cause of TEMPI syndrome is currently unknown. Treatment has reportedly been completely or partially successful with the medication bortezomib.[2][3]
Last updated: 11/6/2012

This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.

Showing of 14 |
Medical Terms Other Names
Learn More:
HPO ID
100% of people have these symptoms
Abnormality of the kidney
Abnormal kidney
0000077
Hypoxemia
Low blood oxygen level
0012418
Increased circulating IgG level 0003237
Increased hematocrit 0001899
Telangiectasia 0001009
80%-99% of people have these symptoms
Abnormality of the pulmonary vasculature
Abnormality of the lung blood vessels
0004930
Ascites
Accumulation of fluid in the abdomen
0001541
Hemangioma
Strawberry mark
0001028
Transudative pleural effusion 0011920
30%-79% of people have these symptoms
Intracranial hemorrhage
Bleeding within the skull
0002170
Polycythemia
Increased red blood cells
0001901
Venous thrombosis
Blood clot in vein
0004936
5%-29% of people have these symptoms
Facial erythema
Blushed cheeks
Blushing
Red face
Red in the face
[ more ] 		0001041
Headache
Headaches
0002315
Showing of 14 |
Last updated: 7/1/2020

These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

In-Depth Information

  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss TEMPI syndrome. Click on the link to view a sample search on this topic.

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.

  1. Sykes DB, Schroyens W, O'Connell C. The TEMPI syndrome--a novel multisystem disease. New England Journal of Medicine. August 3, 2011; 365(5):475-477. http://www.nejm.org/doi/full/10.1056/NEJMc1106670. Accessed 10/23/2012.
  2. Kwok M, Korde N, Landgren O. Bortezomib to Treat the TEMPI Syndrome. New England Journal of Medicine. May 10, 2012; 366(19):1843-1845. http://www.nejm.org/doi/full/10.1056/NEJMc1202649. Accessed 10/23/2012.
  3. Schroyens W, O'Connell C, Sykes DB. Complete and Partial Responses of the TEMPI Syndrome to Bortezomib. New England Journal of Medicine. August 23, 2012; 367(8):778-780. http://www.nejm.org/doi/full/10.1056/NEJMc1205806. Accessed 10/23/2012.